Clinical Trials Browser

Phase 2 × Anatomic Stage IV Breast Cancer AJCC v8 × pembrolizumab × Clear all

NCT04190056 2023-08-31

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Phase 2 Terminated

1 enrolled 4 charts

Anatomic Stage IV Breast Cancer AJCC v8